#MedicalInnovation is an active hashtag on Bluesky. In the last 30 days, 16 people shared 21 posts with it — around 1 a day. Activity is down 43% versus the previous week, peaking on Oct 26 with 3 posts.
purescience.news
A Tiny, Jelly-Like Implant Could Change How We Treat High Blood Pressure
A soft implant that attaches without stitches lowered blood pressure in rats, pointing toward a way to treat hypertension with less damage to surrounding tissue. Nearly half of all adults in the...
citizenportal.ai
Miller Keystone asks county to sponsor $700,000 in blood‑safety equipment via statewide LSA
Miller Keystone Blood Center requested county sponsorship for a statewide LSA application covering two end‑of‑life pieces of equipment — a BacT unit (~$416,000) and an irradiator (~$284,000) — totaling about $700,000, which the presenter said would protect transfusion safety across a multi‑county service area.
dlvr.it
Real-Time Integration of Bronchoscope Video and 3D Airway Models on Apple Vision Pro: Phantom Feasibility Study
This single-operator phantom study demonstrates the technical feasibility of colocating a live bronchoscope video stream with patient-specific 3D airway models on Apple Vision Pro using a native Network Device Interface pipeline, without establishing comparative or clinical benefit.
en.killbait.com
Canadian doctors develop two-step robotic procedure for AFib treatment
Canadian medical professionals have developed a novel two-step procedure that could significantly improve outcomes for patients with atrial fibrillation (AFib), a common heart rhythm disorder. The innovative approach, pioneered by Dr. Paul Angaran and Dr. Gianluigi Bisleri at St. Michael's Hospital in Toronto, combines robotic surgery with catheter ablation techniques to address the limitations of current treatments. AFib, which affects 1-2% of the general population, causes irregular heartbeats that can lead to serious complications including stroke and heart failure. Current standard treatments typically involve either medication or catheter ablation, where doctors create scar tissue in the heart to block irregular electrical signals. However, these methods often prove ineffective for patients with long-standing persistent AFib. The new procedure involves first using robotic technology to create external scars on the heart, followed by a catheter-based technique to treat internal areas. This dual approach allows for more comprehensive treatment of the heart's electrical pathways. Dr. Bisleri explained that the robotic component provides greater precision and access to the heart, while the catheter technique targets specific internal areas. The treatment has shown promising results, with potential success rates of 70-80% for patients with long-standing persistent AFib. One of the first patients to undergo the procedure was Jon Davies from Edmonton, who had been diagnosed with AFib and had previously been told surgery wasn't an option due to his enlarged heart. After learning about the new procedure online, Davies underwent the first part of the treatment in September and is scheduled for the second phase in the coming weeks. He expressed optimism about the potential to move beyond the 'status quo' of lifelong blood thinner medication. The doctors noted that while the procedure is a Canadian first, awareness remains limited, and patients must be referred to their specialized team. The treatment requires a few weeks or months between procedures to allow for healing of the external scars before proceeding with the internal catheter ablation. This advancement represents a significant step forward in cardiac care for AFib patients, offering hope for improved quality of life and reduced risk of complications.
austriareport.com
Lower Austria Expands Regional Tumor Network
Lower Austria is scaling its cancer care network to address rising diagnoses and an aging population under the new Health Plan 2040+.
news.owkid.com
Gene Solutions Showcases Global Evidence and Responsible Innovation in Prenatal and Women's Genomic Health at ISPD 2026
**Gene Solutions Unveils Real-World Evidence in Prenatal and Women’s Genomic Health at ISPD 2026 Conference** At the recent International Society for Prenatal Diagnosis (ISPD) 2026…
purescience.news
A Tiny, Jelly-Like Implant Could Change How We Treat High Blood Pressure
A soft implant that attaches without stitches lowered blood pressure in rats, pointing toward a way to treat hypertension with less damage to surrounding tissue. Nearly half of all adults in the...
citizenportal.ai
Miller Keystone asks county to sponsor $700,000 in blood‑safety equipment via statewide LSA
Miller Keystone Blood Center requested county sponsorship for a statewide LSA application covering two end‑of‑life pieces of equipment — a BacT unit (~$416,000) and an irradiator (~$284,000) — totaling about $700,000, which the presenter said would protect transfusion safety across a multi‑county service area.
dlvr.it
Real-Time Integration of Bronchoscope Video and 3D Airway Models on Apple Vision Pro: Phantom Feasibility Study
This single-operator phantom study demonstrates the technical feasibility of colocating a live bronchoscope video stream with patient-specific 3D airway models on Apple Vision Pro using a native Network Device Interface pipeline, without establishing comparative or clinical benefit.
en.killbait.com
Canadian doctors develop two-step robotic procedure for AFib treatment
Canadian medical professionals have developed a novel two-step procedure that could significantly improve outcomes for patients with atrial fibrillation (AFib), a common heart rhythm disorder. The innovative approach, pioneered by Dr. Paul Angaran and Dr. Gianluigi Bisleri at St. Michael's Hospital in Toronto, combines robotic surgery with catheter ablation techniques to address the limitations of current treatments. AFib, which affects 1-2% of the general population, causes irregular heartbeats that can lead to serious complications including stroke and heart failure. Current standard treatments typically involve either medication or catheter ablation, where doctors create scar tissue in the heart to block irregular electrical signals. However, these methods often prove ineffective for patients with long-standing persistent AFib. The new procedure involves first using robotic technology to create external scars on the heart, followed by a catheter-based technique to treat internal areas. This dual approach allows for more comprehensive treatment of the heart's electrical pathways. Dr. Bisleri explained that the robotic component provides greater precision and access to the heart, while the catheter technique targets specific internal areas. The treatment has shown promising results, with potential success rates of 70-80% for patients with long-standing persistent AFib. One of the first patients to undergo the procedure was Jon Davies from Edmonton, who had been diagnosed with AFib and had previously been told surgery wasn't an option due to his enlarged heart. After learning about the new procedure online, Davies underwent the first part of the treatment in September and is scheduled for the second phase in the coming weeks. He expressed optimism about the potential to move beyond the 'status quo' of lifelong blood thinner medication. The doctors noted that while the procedure is a Canadian first, awareness remains limited, and patients must be referred to their specialized team. The treatment requires a few weeks or months between procedures to allow for healing of the external scars before proceeding with the internal catheter ablation. This advancement represents a significant step forward in cardiac care for AFib patients, offering hope for improved quality of life and reduced risk of complications.
austriareport.com
Lower Austria Expands Regional Tumor Network
Lower Austria is scaling its cancer care network to address rising diagnoses and an aging population under the new Health Plan 2040+.
news.owkid.com
Gene Solutions Showcases Global Evidence and Responsible Innovation in Prenatal and Women's Genomic Health at ISPD 2026
**Gene Solutions Unveils Real-World Evidence in Prenatal and Women’s Genomic Health at ISPD 2026 Conference** At the recent International Society for Prenatal Diagnosis (ISPD) 2026…
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.